Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Context Therapeutics Inc (CNTX)

Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Context Therapeutics Inc 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 USA

www.contexttherapeutics.com P: 267-225-7416

Description:

Context Therapeutics Inc. is a women's oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. Context Therapeutics Inc. is headquartered in Philadelphia, PA.

Key Statistics

Overview:

Market Capitalization, $K 27,948
Enterprise Value, $K 13,498
Shares Outstanding, K 15,970
Annual Sales, $ 0 K
Annual Net Income, $ -23,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,770 K
EBIT, $ -25,070 K
EBITDA, $ -25,060 K
60-Month Beta 2.14
% of Insider Shareholders 6.66%
% of Institutional Shareholders 14.03%
Float, K 14,906
% Float 93.34%
Short Volume Ratio 0.34

Growth:

1-Year Return 255.43%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 03/21/24
Latest Earnings Date 05/08/24 [--]
Earnings Per Share ttm -1.50
EPS Growth vs. Prev Qtr -13.51%
EPS Growth vs. Prev Year -90.91%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CNTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -115.50%
Return-on-Assets % -97.04%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.81
Book Value/Share 0.74
Interest Coverage -2.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar